This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Hansoh Pharmaceutical Group Co., Ltd., Shanghai Hansoh Biomedical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Peng Gao
Introduction
Peng Gao is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for cancer treatment. His work is characterized by a focus on innovative chemical compounds that target specific biological pathways.
Latest Patents
Peng Gao holds a patent for "Tricyclic derivatives inhibitor, preparation method, and applications thereof." This patent describes an inhibitor containing a tricyclic derivative, a preparation method for the inhibitor, and a pharmaceutical composition that includes the inhibitor. The invention is particularly relevant as a phosphoinositide 3 kinase (PI3K) inhibitor, which is crucial in the treatment of cancer and other diseases or conditions that are mediated by or dependent on PI3K imbalance. He has 1 patent to his name.
Career Highlights
Throughout his career, Peng Gao has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Shanghai Hansoh Biomedical Co., Ltd. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in drug development.
Collaborations
Peng Gao has collaborated with several professionals in his field, including Guangjun Sun and Shaobao Wang. These collaborations have further enhanced his research and development efforts, leading to impactful innovations in pharmaceuticals.
Conclusion
Peng Gao's contributions to the field of pharmaceuticals, particularly through his patent on tricyclic derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and related medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile